Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
IS05 - Industry Symposium Sponsored by Merck Kgaa Darmstadt: Decisive Moments in the Treatment of MET exon 14 Skipping NSCLC
- 13:15 - 14:15
- 8/06/2022
- Location: Hall C7
- Not for CME Credit
- Type: Industry Symposium
- Track: N/A
-
+
Session Moderator
13:15 - 13:15 | Presenter: Sanjay Popat
- Abstract
Loading... -
+
IS05.01 - A Moment to Welcome You
13:15 - 13:20 | Presenter: Sanjay Popat
- Abstract
Loading... -
+
IS05.06 - A Moment to Reflect on METex14 Skipping
14:10 - 14:15 | Presenter: Sanjay Popat
- Abstract
Loading...
-
+
EP07.03 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Thymoma
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Thymoma
-
+
EP07.03-005 - MesoGraph: Graph Neural Networks for Weakly Supervised Cellular Profiling in the Subtyping of Malignant Mesothelioma Images
Presenter: Mark Eastwood- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
EP08.02-065 - Response to Systemic Anti-Cancer Therapy in Uncommon EGFR Mutations
Presenter: Hazel M O'Sullivan- Abstract
Loading... -
+
EP08.02-124 - Lorlatinib Treatment Related Adverse Events: Single Centre Real-World Experience in ALK and ROS1-driven NSCLC
Presenter: PARVIN BEGUM- Abstract
Loading... -
+
EP08.02-171 - PRO-CTCAE Analysis of Mobocertinib in EGFR Exon 20 Insertion‒Positive Metastatic Non‒Small Cell Lung Cancer (NSCLC)
Presenter: Rosario Garcia- Abstract
Loading...
-
+
EP08.03 - Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease
-
+
EP08.03-005 - HALT - Targeted Therapy with or without Dose-Intensified Radiotherapy in Oligo-Progressive Disease in Oncogene Addicted Lung Tumours
Presenter: Fiona McDonald- Abstract
Loading...
-
+
EP11.03 - Pathology - Tumour Biology
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Pathology - Tumour Biology
-
+
EP11.03-003 - Adenocarcinoma Grade Correlates with PD-L1 and TP53, but not EGFR/KRAS Status and Diagnostic Yield: Analysis of 346 Cases
Presenter: Yu Zhi Zhang- Abstract
Loading...
-
+
P1.12 - Management of Lung Cancer in the Era of COVID-19
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Management of Lung Cancer in the Era of COVID-19
-
+
P1.12-05 - Prediction of Clinically Significant Pathological Upstaging in Resected Lung Cancer: Insight from COVID-19 Pandemic (1st wave)
Presenter: Yu Zhi Zhang- Abstract
Loading...
-
+
ES25 - Clinical Issues with Immunotherapy in Non-small Cell Lung Cancer
- 16:00 - 17:00
- 8/08/2022
- Location: Hall C1
- IASLC CME Accredited
- Type: Education Session
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Moderators:Martin Reck, Sanjay Popat
-
+
Session Moderator
16:38 - 16:50 | Presenter: Martin Reck
- Abstract
Loading... -
+
Session Moderator
16:38 - 16:50 | Presenter: Sanjay Popat
- Abstract
Loading... -
+
ES25.01 - Session Introduction
16:00 - 16:01 | Presenter: Martin Reck
- Abstract
Loading... -
+
ES25.02 - Session Introduction
16:01 - 16:02 | Presenter: Sanjay Popat
- Abstract
Loading... -
+
ES25.03 - First-Line Choice in PD-L1 Positive Patients
16:02 - 16:14 | Presenter: Filiz Oezkan
- Abstract
Loading... -
+
ES25.04 - First-Line Choice in PD-L1 Negative Patients
16:14 - 16:26 | Presenter: Delvys Rodriguez-Abreu
- Abstract
Loading... -
+
ES25.05 - Second-Line Options in Immune-Pretreated Patients
16:26 - 16:38 | Presenter: Keunchil Park
- Abstract
Loading... -
+
ES25.06 - Immunotherapy in Oncogene-Addicted NSCLC
16:38 - 16:50 | Presenter: Francesco Passiglia
- Abstract
Loading... -
+
ES25.07 - Live Q&A
16:50 - 17:00
- Abstract
Loading...
-
+
MA12 - Pathology: Tumour Diagnostics
- 10:45 - 11:45
- 8/09/2022
- Location: Hall C7
- Not for CME Credit
- Type: Mini Oral
- Track: Pathology
- Moderators:Aleks Ryska, Deepali Jain
-
+
MA12.09 - Frequency and Detectability of Uncommon EGFR Mutations in NSCLC
11:22 - 11:27 | Presenter: Hazel M O'Sullivan
- Abstract
Loading...
